1. Home
  2. Blogs for October, 2021

Month: October 2021

KKR, Round Hill Capital and Pulsar Properties Announce the Sale of Their Spanish Logistics Portfolio Joint Venture, PULSAR IBERIA LOGISTICS, to P3 Logistics Parks for €108.3m

LONDON--(BUSINESS WIRE)-- KKR, a leading global investment firm, and Round Hill Capital (“RHC”), a leading real estate investment, development and asset management firm, and Pulsar Properties, a renowned logistics developer in Spain of industrial, logistics

ArchiMed invests in Xpress Biologics

ArchiMed has invested in plasmid DNA and protein therapeutics developer Xpress Biologics, with the intention of implementing a tenfold production capacity increase for the company.

CIFC launches $2bn leveraged loans platform with Texas pension fund

Opalesque Industry Update - Teacher Retirement System of Texas (TRS) and CIFC Asset Management LLC (CIFC) have announced the creation of a new leveraged loan investment fund platform known as Texas Debt Capital LP (TDC).

Graycliff Partners picks up precision semiconductor components specialist CHawk Technology

Graycliff Partners has completed an equity investment and recapitalisation of CHawk Technology International, a maker of precision components and assemblies for the semiconductor capital equipment, aerospace, and medical device industries. The post Graycliff Partners picks

San Giorgio in sale talks with Ergon, reviews valuation expectations

San Giorgio, an Italian commercial bakery, is in preliminary sale talks with private equity house Ergon, according to two sources familiar with the situation.

European PE activity could reach EUR 400bn mark in 2021

Europe was home to a record number of deals in the first nine months of the year, with Unquote estimating that the aggregate value of investments could approach EUR 400bn by year-end.

Acon sells off industrial segment of IIMAK, three years after buyout from Altus Capital

Acon Investments has agreed to sell the industrial segment of specialist print consumables business International Imaging Materials to trade buyer Armor USA. The post Acon sells off industrial segment of IIMAK, three years after buyout

ArchiMed looks to replicate impressive Polyplus success with investment in DNA producer Xpress Biologics

Healthcare-focused buyout house ArchiMed has bought into Belgium-based Xpress Biologics to finance a 10x expansion of its production capacity, the firm said. The post ArchiMed looks to replicate impressive Polyplus success with investment in DNA producer

Vista’s credit arm surfs past target to close third fund on $2.3bn

Vista Credit Partners has hit a $2.3bn final close for Vista Credit Partners Fund III, beating its original $1.5bn target. The post Vista’s credit arm surfs past target to close third fund on $2.3bn first

Huge post-Covid growth for mParticle attracts Permira, others for $150m Series E round

Global private equity major Permira has led a $150m Series E round for customer data infrastructure company mParticle in the wake of massive adoption in the wake of Covid-19. The post Huge post-Covid growth for

Lightning $5.6bn fundraise sees Thomas H Lee Partners hit Fund IX hard cap in just three months

A lightning fundraise from Thomas H Lee Partners has seen the firm strike a $5.6bn hard cap final close for its ninth flagship fund after just three months in the market. The post Lightning $5.6bn

How LA buyout house Diversis turned the crisis of Covid into a striking fundraising success

Traditional wisdom might tell you there are opportunities in every risk – but in times of uncertainty, it is just sometimes not so easily compensable. The Covid-19 pandemic has been one of the most uncertain times globally in recent human

KKR boosts opportunistic real estate capital to over $8bn with new fund close

KKR has hit a $4.3bn final close for its third US-focused opportunistic real estate fund, more than double the size of its predecessor in the strategy. The post KKR boosts opportunistic real estate capital to

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.